Liangjun Wang

7.7k total citations · 2 hit papers
69 papers, 5.9k citations indexed

About

Liangjun Wang is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Liangjun Wang has authored 69 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 14 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Liangjun Wang's work include Epigenetics and DNA Methylation (11 papers), Autophagy in Disease and Therapy (10 papers) and Cancer-related gene regulation (9 papers). Liangjun Wang is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), Autophagy in Disease and Therapy (10 papers) and Cancer-related gene regulation (9 papers). Liangjun Wang collaborates with scholars based in Taiwan, China and United States. Liangjun Wang's co-authors include Richard S. Jones, Yi Zhang, Hengbin Wang, Hediye Erdjument‐Bromage, Paul Tempst, Ru Cao, Li Xia, Miguel Vidal, Marc J. Mass and J. Lesley Brown and has published in prestigious journals such as Nature, Science and Advanced Materials.

In The Last Decade

Liangjun Wang

67 papers receiving 5.8k citations

Hit Papers

Role of Histone H3 Lysine 27 Methylation in Polycomb-Grou... 2002 2026 2010 2018 2002 2004 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
    2002 2.9k citations Ru Cao, Liangjun Wang et al. Science profile →
  2. Role of histone H2A ubiquitination in Polycomb silencing
    2004 1.3k citations Hengbin Wang, Liangjun Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangjun Wang Taiwan 19 5.0k 707 661 426 417 69 5.9k
Paul A. Cloos Denmark 29 4.9k 1.0× 854 1.2× 570 0.9× 609 1.4× 182 0.4× 46 6.1k
Jiang Liu China 27 3.3k 0.7× 588 0.8× 634 1.0× 399 0.9× 310 0.7× 66 4.0k
Han Han China 26 3.0k 0.6× 339 0.5× 848 1.3× 546 1.3× 333 0.8× 105 4.1k
Tej K. Pandita United States 46 5.2k 1.0× 544 0.8× 969 1.5× 1.3k 3.0× 379 0.9× 125 6.4k
F. Jeffrey Dilworth Canada 41 4.6k 0.9× 1.0k 1.4× 587 0.9× 355 0.8× 138 0.3× 75 5.4k
François Gaudet United States 16 3.5k 0.7× 708 1.0× 468 0.7× 559 1.3× 189 0.5× 23 4.1k
Lluís Morey United States 26 4.1k 0.8× 595 0.8× 684 1.0× 436 1.0× 155 0.4× 41 4.6k
Li Xia China 15 3.6k 0.7× 489 0.7× 660 1.0× 296 0.7× 307 0.7× 41 4.2k
Jan Karlseder United States 42 7.3k 1.4× 564 0.8× 613 0.9× 876 2.1× 896 2.1× 67 9.4k
Hao Zhu United States 37 4.4k 0.9× 628 0.9× 1.6k 2.4× 471 1.1× 157 0.4× 116 6.2k

Countries citing papers authored by Liangjun Wang

Since Specialization
Citations

This map shows the geographic impact of Liangjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangjun Wang more than expected).

Fields of papers citing papers by Liangjun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangjun Wang. The network helps show where Liangjun Wang may publish in the future.

Co-authorship network of co-authors of Liangjun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liangjun Wang. A scholar is included among the top collaborators of Liangjun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangjun Wang. Liangjun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Li-Yuan, et al.. (2025). A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cells. International Journal of Medical Sciences. 22(5). 1081–1091. 2 indexed citations
2.
3.
Luo, Chengyang, Cheng Chen, Xinglong Zhang, et al.. (2024). High‐Temperature Resistance Photoluminescence Carbonized Polymer Dots Through Equilibrium Bi‐Confinement Effects. Advanced Materials. 37(5). e2407811–e2407811. 7 indexed citations
4.
Sun, Jinfeng, et al.. (2024). Incidence of second primary cancers in patients with retinoblastoma: a systematic review and meta-analysis. Frontiers in Oncology. 14. 1372548–1372548. 2 indexed citations
5.
Leung, Wendy, Ryan M. Baxley, Liangjun Wang, et al.. (2023). FANCD2-dependent mitotic DNA synthesis relies on PCNA K164 ubiquitination. Cell Reports. 42(12). 113523–113523. 8 indexed citations
6.
Lin, Kevin, Ryan M. Baxley, Liangjun Wang, et al.. (2023). RNF4 and USP7 cooperate in ubiquitin-regulated steps of DNA replication. Open Biology. 13(8). 230068–230068. 6 indexed citations
7.
Wu, Haibo, et al.. (2023). Solar Energy for Value-Added Chemical Production by Light-Powered Microbial Factories. CCS Chemistry. 6(7). 1776–1788. 9 indexed citations
8.
Chiou, Jing‐Ting, Yuan‐Chin Lee, Liangjun Wang, & Long‐Sen Chang. (2022). BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells. Chemico-Biological Interactions. 361. 109978–109978. 14 indexed citations
9.
Chiou, Jing‐Ting, Liangjun Wang, Yuan‐Chin Lee, & Long‐Sen Chang. (2021). Naja atra Cardiotoxin 1 Induces the FasL/Fas Death Pathway in Human Leukemia Cells. Cells. 10(8). 2073–2073. 13 indexed citations
10.
Wang, Liangjun, Jing‐Ting Chiou, Yuan‐Chin Lee, & Long‐Sen Chang. (2021). Docetaxel-triggered SIDT2/NOX4/JNK/HuR signaling axis is associated with TNF-α-mediated apoptosis of cancer cells. Biochemical Pharmacology. 195. 114865–114865. 17 indexed citations
11.
Chiou, Jing‐Ting, Yuan‐Chin Lee, Chia‐Hui Huang, et al.. (2021). Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells. Biochemical Pharmacology. 188. 114544–114544. 10 indexed citations
12.
Huang, Chia‐Hui, Yuan‐Chin Lee, Jing‐Ting Chiou, et al.. (2020). Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells. Toxicology and Applied Pharmacology. 397. 115013–115013. 18 indexed citations
13.
Lee, Yuan‐Chin, Liangjun Wang, Chia‐Hui Huang, et al.. (2020). Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation. Biochemical Pharmacology. 178. 114047–114047. 3 indexed citations
14.
Chiou, Jing‐Ting, Yuan‐Chin Lee, Chia‐Hui Huang, et al.. (2019). Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells. Toxicology and Applied Pharmacology. 387. 114857–114857. 13 indexed citations
15.
Shi, Yijun, Chia‐Hui Huang, Yuan‐Chin Lee, et al.. (2019). Naja atra cardiotoxins enhance the protease activity of chymotrypsin. International Journal of Biological Macromolecules. 136. 512–520. 11 indexed citations
16.
Cao, Ru, Liangjun Wang, Hengbin Wang, et al.. (2002). Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing. Science. 298(5595). 1039–1043. 2927 indexed citations breakdown →
17.
Xiao, Zefen, Jun Liang, Mei Wang, et al.. (2002). [Clinical value of prophylactic radiotherapy after curative resection of esophageal carcinoma].. PubMed. 24(6). 608–11. 3 indexed citations
18.
O’Connell, Sinead, et al.. (2001). Polycomblike PHD Fingers Mediate Conserved Interaction with Enhancer of Zeste Protein. Journal of Biological Chemistry. 276(46). 43065–43073. 91 indexed citations
19.
Wang, Yonggang, Liangjun Wang, De-Chao Zhang, Rugang Zhang, & Dawei Zhang. (2000). Surgical treatment of primary esophageal small-cell carcinoma. Chinese Journal of Cancer Research. 12(1). 75–78. 2 indexed citations
20.
Wang, Yonggang, Dawei Zhang, Liangjun Wang, et al.. (1999). Surgical treatment of primary esophageal adenocarcinoma. Chinese Journal of Cancer Research. 11(1). 44–48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul A. Cloos Breakdown of academic impact, for papers by Jiang Liu Breakdown of academic impact, for papers by Han Han Breakdown of academic impact, for papers by Tej K. Pandita Breakdown of academic impact, for papers by F. Jeffrey Dilworth Breakdown of academic impact, for papers by François Gaudet Breakdown of academic impact, for papers by Lluís Morey Breakdown of academic impact, for papers by Li Xia Breakdown of academic impact, for papers by Jan Karlseder Breakdown of academic impact, for papers by Hao Zhu
Rankless by CCL
2026